LGND Rule 144 notices: 467-share sales reported

LGND Rule 144 notice discloses reported dispositions of Common stock.

Rhea-AI Filing Summary

LGND Rule 144 notice discloses reported dispositions of Common stock. The filing lists an issuer broker entry at UBS Financial Services and shows multiple reported sales by John Kozarich of 467 shares on 01/02/2026, 02/02/2026, and 03/02/2026 with reported amounts $88,532.51, $91,490.02, and $93,632.38 respectively.

Insights

Compliance Analyst

Routine Rule 144 sale notices showing multiple small dispositions by a single holder.

The excerpt lists Rule 144 transaction rows for Common stock, including three disposition dates for John Kozarich with identical share counts (467) and associated dollar figures. The entry names UBS Financial Services as a securities entry point.

These entries appear administrative: they document reported sales under Rule 144 rather than company operational news. Subsequent filings or Form 4/5 may provide additional context.

Key Figures

Shares per disposition: 467 shares Proceeds (02/02/2026 line): $91,490.02 Proceeds (01/02/2026 line): $88,532.51 +2 more

5 metrics

Shares per disposition 467 shares each reported sale on 01/02/2026, 02/02/2026, 03/02/2026

Proceeds (02/02/2026 line) $91,490.02 reported alongside 02/02/2026 disposition

Proceeds (01/02/2026 line) $88,532.51 reported alongside 01/02/2026 disposition

Proceeds (03/02/2026 line) $93,632.38 reported alongside 03/02/2026 disposition

Filing date or reference 04/01/2026 date shown near issuer securities header

Key Terms

Rule 144, Issuer, Securities Sold During The Past 3 Months

3 terms

Rule 144 regulatory

"144: Securities To Be Sold"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Issuer financial

"Common | 04/24/2024 | Various | Issuer"

Securities Sold During The Past 3 Months regulatory

"144: Securities Sold During The Past 3 Months"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the LGND Form 144 disclose?

It discloses Rule 144 sale notices of Common stock by an issuer-designated broker. The filing lists three reported dispositions by John Kozarich of 467 shares on 01/02/2026, 02/02/2026, and 03/02/2026 with associated figures.

Who is the reported seller in the LGND excerpt?

The reported seller is John Kozarich, with an address listed in San Diego. The excerpt shows three disposition lines tied to his name on 01/02/2026, 02/02/2026, and 03/02/2026.

How many shares were reported sold in each transaction?

Each reported disposition lists 467 shares. The three dated entries for 01/02/2026, 02/02/2026, and 03/02/2026 each show the same share count of 467.

What dollar figures accompany the reported sales?

The excerpt shows numeric amounts next to each disposition: $88,532.51 (01/02/2026), $91,490.02 (02/02/2026), and $93,632.38 (03/02/2026). The filing presents these figures alongside the sale rows.

Where is the broker or issuer entry listed for these securities?

The filing lists UBS Financial Services, Inc., Eleven Madison Avenue, 4th Floor, New York NY 10010 as the securities-related entry and indicates Nasdaq as the market reference.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/01/2026 - 04:10 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001223000
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	LIGAND PHARMACEUTICALS INC
SEC File Number	001-33093
Address of Issuer	3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CALIFORNIA 92121
Phone	858-550-7500
Name of Person for Whose Account the Securities are To Be Sold	KOZARICH JOHN W
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc. Eleven Madison Avenue 4th Floor New York NY 10010	467	95034.50	19941141	04/01/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/24/2024	Various	Issuer			467	04/24/2024	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
John Kozarich 3911 Sorrentino Valley Blvd. Suite 110 San Diego CA 92121	Common	02/02/2026	467	91490.02
John Kozarich 3911 Sorrentino Valley Boulevard Suite 110 San Diego CA 92121	Common	01/02/2026	467	88532.51
John Kozarich 3911 Sorrentino Valley Boulevard Suite 110 San Diego CA 92121	Common	03/02/2026	467	93632.38

144: Remarks and Signature

Remarks
Date of Notice	04/01/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/07/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services Inc, as attorney-in-fact for John Kozarich
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)